Collins P, Fox CP, George LC, Pearce H, Ryan GB, De Santo C, Mussai FJ, Lewis D, Long HM, Shannon-Lowe CD. Characterising EBV-associated lymphoproliferative diseases and the role of myeloid-derived suppressor cells. Blood. 2020 Aug 25:blood.2020005611. doi: 10.1182/blood.2020005611. Epub ahead of print. PMID: 32842145.
Fultang L, Booth S, Yogev O, Martins da Costa B, Tubb V, Panetti S, Stavrou V, Scarpa U, Jankevics A, Lloyd G, Southam A, Lee SP, Dunn WB, Chesler L, Mussai F, De Santo C. Metabolic engineering against the arginine microenvironment enhances CAR-T cell proliferation and therapeutic activity. Blood. 2020 Sep 3;136(10):1155-1160. doi: 10.1182/blood.2019004500. PMID: 32573723; PMCID: PMC7565134.
Fultang L, Panetti S, Ng M, Collins P, Graef S, Rizkalla N, Booth S, Lenton R, Noyvert B, Shannon-Lowe C, Middleton G, Mussai F, De Santo C. MDSC targeting with Gemtuzumab ozogamicin restores T cell immunity and immunotherapy against cancers. EBioMedicine. 2019 Sep;47:235-246. doi: 10.1016/j.ebiom.2019.08.025. Epub 2019 Aug 25. PMID: 31462392; PMCID: PMC6796554.
Petrof G, Casey GA, Colmenero I, Mussai F, Gach JE. Disseminated Congenital Malignant Rhabdoid Tumor Misdiagnosed as Multiple Congenital Hemangiomas. J Pediatr Hematol Oncol. 2020 Jan;42(1):79-80. doi: 10.1097/MPH.0000000000001587. PMID: 31415283.
Craddock C, Slade D, De Santo C, Wheat R, Ferguson P, Hodgkinson A, Brock K, Cavenagh J, Ingram W, Dennis M, Malladi R, Siddique S, Mussai F, Yap C. Combination Lenalidomide and Azacitidine: A Novel Salvage Therapy in Patients Who Relapse After Allogeneic Stem-Cell Transplantation for Acute Myeloid Leukemia. J Clin Oncol. 2019 Mar 1;37(7):580-588. doi: 10.1200/JCO.18.00889. Epub 2019 Jan 17. PMID: 30653424; PMCID: PMC6494237.
Cader FZ, Colmenero I, Mussai F. Hemophagocytic Lymphohistiocytosis Associated With 2 Cases of Pediatric Lymphocyte-depleted Classic Hodgkin Lymphoma. J Pediatr Hematol Oncol. 2019 Jul;41(5):e341-e345. doi: 10.1097/MPH.0000000000001398. PMID: 30601404.
Fultang L, Gamble LD, Gneo L, Berry AM, Egan SA, De Bie F, Yogev O, Eden GL, Booth S, Brownhill S, Vardon A, McConville CM, Cheng PN, Norris MD, Etchevers HC, Murray J, Ziegler DS, Chesler L, Schmidt R, Burchill SA, Haber M, De Santo C, Mussai F. Macrophage-Derived IL1β and TNFα Regulate Arginine Metabolism in Neuroblastoma. Cancer Res. 2019 Feb 1;79(3):611-624. doi: 10.1158/0008-5472.CAN-18-2139. Epub 2018 Dec 13. PMID: 30545920; PMCID: PMC6420118.
Bokori-Brown M, Metz J, Petrov PG, Mussai F, De Santo C, Smart NJ, Saunders S, Knight B, Pastan I, Titball RW, Winlove CP. Interactions Between Pseudomonas Immunotoxins and the Plasma Membrane: Implications for CAT-8015 Immunotoxin Therapy. Front Oncol. 2018 Nov 27;8:553. doi: 10.3389/fonc.2018.00553. PMID: 30538953; PMCID: PMC6277520.
Mussai F, Wheat R, Sarrou E, Booth S, Stavrou V, Fultang L, Perry T, Kearns P, Cheng P, Keeshan K, Craddock C, De Santo C. Targeting the arginine metabolic brake enhances immunotherapy for leukaemia. Int J Cancer. 2019 Oct 15;145(8):2201-2208. doi: 10.1002/ijc.32028. Epub 2019 Jan 11. PMID: 30485425; PMCID: PMC6767531.
De Santo C, Cheng P, Beggs A, Egan S, Bessudo A, Mussai F. Metabolic therapy with PEG-arginase induces a sustained complete remission in immunotherapy- resistant melanoma. J Hematol Oncol. 2018 May 18;11(1):68. doi: 10.1186/s13045-018-0612-6. PMID: 29776373; PMCID: PMC5960181.
See Dr Francis Mussai's full list of publications.